Literature DB >> 9175808

Multicenter evaluation of the flow cytometry T-cell crossmatch: results from the American Society of Histocompatibility and Immunogenetics-College of American Pathologists proficiency testing program.

J C Scornik1, R A Bray, M S Pollack, D J Cook, M Marrari, R Duquesnoy, J W Langley.   

Abstract

BACKGROUND: The performance characteristics and interlaboratory comparisons of the T-cell flow cytometry crossmatch remain largely unknown.
METHODS: This study was performed using data from the ASHI-CAP proficiency testing program. Four unknown sera and two unknown cells were sent to participating laboratories twice a year for 4 years.
RESULTS: In one survey in which different crossmatch techniques were compared, flow cytometry was slightly more sensitive than the antiglobulin method and considerably more sensitive than direct cytotoxicity. However, the proportion of participants in any given survey detecting antibodies in all sera expected to be positive was 50-60% and has not changed over the years. Failure to detect antibodies correlated with low antibody concentration, diluting the unknown serum by the testing laboratory, and with the instrument used. False positive results with normal sera were infrequent. Fluorescence intensity values were not standardized and were highly variable, but when fluorescence units reported by individual laboratories were divided by their own positive-negative cutoff values, results from different centers were more comparable. In general, fluorescence-to-cutoff ratios >5 correlated with complement binding activity, whereas values <5 denoted concentrations below those required to fix complement.
CONCLUSIONS: Flow cytometry, as used by most centers, is highly sensitive and allows relative antibody quantitation. Furthermore, the data define objective parameters that may help to standardize the test and improve its predictive value in clinical transplantation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9175808     DOI: 10.1097/00007890-199705270-00013

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  6 in total

Review 1.  Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.

Authors:  Gerald Schlaf; Beatrix Pollok-Kopp; Wolfgang W Altermann
Journal:  Mol Diagn Ther       Date:  2014-04       Impact factor: 4.074

Review 2.  Transplant immuno-diagnostics: crossmatch and antigen detection.

Authors:  Andrew M South; Paul C Grimm
Journal:  Pediatr Nephrol       Date:  2015-07-03       Impact factor: 3.714

3.  Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching.

Authors:  Gerald Schlaf; Beatrix Pollok-Kopp; Till Manzke; Oliver Schurat; Wolfgang Altermann
Journal:  NDT Plus       Date:  2010-09-15

Review 4.  Human leukocyte antigen typing and crossmatch: A comprehensive review.

Authors:  Mohammed Mahdi Althaf; Mohsen El Kossi; Jon Kim Jin; Ajay Sharma; Ahmed Mostafa Halawa
Journal:  World J Transplant       Date:  2017-12-24

5.  Technical and clinical aspects of the histocompatibility crossmatch assay in solid organ transplantation

Authors:  Ana María Arrunátegui; Daniel S Ramón; Luz Marina Viola; Linda G Olsen; Andrés Jaramillo
Journal:  Biomedica       Date:  2022-06-01       Impact factor: 1.173

6.  ELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors' Cell Lysates.

Authors:  G Schlaf; K Stöhr; A Rothhoff; W Altermann
Journal:  Case Rep Transplant       Date:  2015-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.